Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L; NN8022-1807 Investigators. Astrup A, et al. Among authors: rossner s. Int J Obes (Lond). 2012 Jun;36(6):843-54. doi: 10.1038/ijo.2011.158. Epub 2011 Aug 16. Int J Obes (Lond). 2012. PMID: 21844879 Free PMC article. Clinical Trial.
Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial).
van Baak MA, van Mil E, Astrup AV, Finer N, Van Gaal LF, Hilsted J, Kopelman PG, Rössner S, James WP, Saris WH; STORM Study Group. van Baak MA, et al. Among authors: rossner s. Am J Clin Nutr. 2003 Aug;78(2):209-14. doi: 10.1093/ajcn/78.2.209. Am J Clin Nutr. 2003. PMID: 12885699 Clinical Trial.
Obesity in Europe - does anybody care?
Astrup A, Rössner S, Finer N, Van Gaal L. Astrup A, et al. Among authors: rossner s. Expert Opin Pharmacother. 2013 Jun;14(8):971-3. doi: 10.1517/14656566.2013.783016. Epub 2013 Mar 22. Expert Opin Pharmacother. 2013. PMID: 23517073 No abstract available.
[Alternative causes of obesity].
Astrup AV, Rössner S, Sørensen TI. Astrup AV, et al. Among authors: rossner s. Ugeskr Laeger. 2006 Jan 9;168(2):135-7. Ugeskr Laeger. 2006. PMID: 16403335 Danish.
Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).
Kopelman P, Groot Gde H, Rissanen A, Rossner S, Toubro S, Palmer R, Hallam R, Bryson A, Hickling RI. Kopelman P, et al. Among authors: rossner s. Obesity (Silver Spring). 2010 Jan;18(1):108-15. doi: 10.1038/oby.2009.155. Epub 2009 May 21. Obesity (Silver Spring). 2010. PMID: 19461584 Free article. Clinical Trial.
720 results